Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?

Affiliations

• ¹ Robert H Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL.
• ² Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
• ³ The Christie and Salford Royal Hospitals, Manchester University, Manchester, England.
• ⁴ Institut Gustave Roussy, University of Paris Saclay, Paris, France.
• ⁵ Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland.
• ⁶ University of Bern, Division of Cancer Sciences, Bern, Switzerland.
• ⁷ University of Manchester, Manchester, England.
• ⁸ Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
• ⁹ Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY.
• ¹⁰ Division of Urology and GU Oncology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada.
• ¹¹ Tulane Cancer Center, Tulane Medical School, New Orleans, LA.
• ¹² Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
• ¹³ Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
• ¹⁴ Peter MacCalllum Cancer Center and University of Melbourne, Melbourne, Australia.